Human tissues contain two types of phosphomannomutase, PMM1 and PMM2. Mutat
ions in the PMM2 gene are responsible for the most common form of carbohydr
ate-deficient glycoprotein syndrome [Matthijs, Schollen, Pardon, Veiga-da-C
unha, Jaeken, Cassiman and Van Schaftingen (1997) Nat. Genet. 19, 88-92]. T
he protein encoded by this gene has now been produced in Escherichia coli a
nd purified to homogeneity, and its properties have been compared with thos
e of recombinant human PMM1. PMM2 converts mannose 1-phosphate into mannose
6-phosphate about 20 times more rapidly than glucose 1-phosphate to glucos
e 6-phosphate, whereas PMM1 displays identical V-max values with both subst
rates. The K(a)values for both mannose 1,6-bisphosphate and glucose 1,6-bis
phosphate are significantly lower in the case of PMM2 than in the case of P
MM1. Like PMM1, PMM2 forms a phosphoenzyme with the chemical characteristic
s of an acyl-phosphate. PMM1 and PMM2 hydrolyse different hexose bisphospha
tes (glucose 1,6-bisphosphate, mannose 1,6-bisphosphate, fructose 1,6-bisph
osphate) at maximal rates of approximate to 3.5 and 0.3% of their PMM activ
ity, respectively. Fructose 1,6-bisphosphate does not activate PMM2 but cau
ses a time-dependent stimulation of PMM1 due to the progressive formation o
f mannose 1,6-bisphosphate from fructose 1,6-bisphosphate and mannose 1-pho
sphate. Experiments with specific antibodies, kinetic studies and Northern
blots indicated that PMM2 is the only detectable isozyme in most rat tissue
s except brain and lung, where PMM1 accounts for about 66 and 13%, of the t
otal activities, respectively.